ADAR1 Capital Management, LLC
274 holdingsFiling period: 2026-06-30Current AUM: $1.98Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ABVX | Abivax SA | 1.85M | $246.4M | $160.9M | 8.12% | +411.1K | 2026-06-30 |
| 2 | PTGX | Protagonist Therapeutics Inc | 960.9K | $117.8M | $135.6M | 6.84% | -33,256 | 2026-06-30 |
| 3 | SPY | State Str Spdr S&P 500 ETF T | 154.1K | $115.1M | $118.6M | 5.98% | +78.1K | 2026-06-30 |
| 4 | — | Roivant Sciences Ltd | 3.16M | $111.7M | $111.7M | 5.64% | -128,898 | 2026-06-30 |
| 5 | IMVT | Immunovant Inc | 2.33M | $89.8M | $67.3M | 3.40% | -348,294 | 2026-06-30 |
| 6 | ZLAB | Zai Lab Ltd | 3.37M | $64.0M | $79.4M | 4.01% | +1.94M | 2026-06-30 |
| 7 | AGIO | Agios Pharmaceuticals Inc | 1.29M | $47.8M | $49.0M | 2.47% | +1.15M | 2026-06-30 |
| 8 | CRNX | Crinetics Pharmaceuticals in | 1.22M | $45.7M | $45.7M | 2.31% | +82.7K | 2026-06-30 |
| 9 | BOXX | EA Series Trust | 337.1K | $39.5M | $40.0M | 2.02% | -- | 2026-06-30 |
| 10 | CYTK | Cytokinetics Inc | 457.9K | $39.0M | $28.2M | 1.42% | -174,649 | 2026-06-30 |
| 11 | SEPN | Septerna Inc | 940.7K | $31.5M | $41.5M | 2.10% | -149,071 | 2026-06-30 |
| 12 | AVR | Anteris Technologies Global | 3.15M | $31.0M | $18.9M | 0.95% | -644,036 | 2026-06-30 |
| 13 | EDIT | Editas Medicine Inc | 8.89M | $28.8M | $23.1M | 1.17% | -- | 2026-06-30 |
| 14 | DNLI | Denali Therapeutics Inc | 1.03M | $26.5M | $19.8M | 1.00% | -842,375 | 2026-06-30 |
| 15 | SYRE | Spyre Therapeutics Inc | 284.0K | $25.2M | $28.1M | 1.42% | -54,341 | 2026-06-30 |
| 16 | VIR | Vir Biotechnology Inc | 2.46M | $25.0M | $28.4M | 1.43% | -288,037 | 2026-06-30 |
| 17 | PRAX | Praxis Precision Medicines I | 74.3K | $24.9M | $19.9M | 1.00% | +72.8K | 2026-06-30 |
| 18 | INSM | Insmed Inc | 228.5K | $24.4M | $21.7M | 1.10% | +193.1K | 2026-06-30 |
| 19 | CLDX | Celldex Therapeutics Inc New | 619.5K | $23.1M | $18.7M | 0.94% | +191.7K | 2026-06-30 |
| 20 | VKTX | Viking Therapeutics Inc | 574.0K | $22.4M | $14.3M | 0.72% | +346.3K | 2026-06-30 |
| 21 | TSHA | Taysha Gene Therapies Inc | 3.04M | $20.7M | $12.9M | 0.65% | +61.0K | 2026-06-30 |
| 22 | MNPR | Monopar Therapeutics Inc | 217.6K | $20.1M | $15.6M | 0.79% | -46,683 | 2026-06-30 |
| 23 | OVID | Ovid Therapeutics Inc | 7.42M | $20.0M | $16.8M | 0.85% | +2.87M | 2026-06-30 |
| 24 | ELVN | Enliven Therapeutics Inc | 387.7K | $19.7M | $16.9M | 0.85% | +58.2K | 2026-06-30 |
| 25 | ENTA | Enanta Pharmaceuticals Inc | 1.34M | $19.6M | $16.4M | 0.83% | +1.29M | 2026-06-30 |
← Scroll →
Page 1 of 11